Meropenem in the treatment of complicated skin and soft tissue infections

about

Fabrication of electrospun polycaprolactone coated withchitosan-silver nanoparticles membranes for wound dressing applications.Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics

P2860

Q36130804-3F523584-6A8F-47BD-ACBB-FF555EB86F4A Q59135453-3B9C9F27-93FF-4178-B8B9-575C2BA5D80D

P2860

Meropenem in the treatment of complicated skin and soft tissue infections

Item

http://www.wikidata.org/entity/Q35919254

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Meropenem in the treatment of complicated skin and soft tissue infections

@ast

Meropenem in the treatment of complicated skin and soft tissue infections

@en

type

Item

label

Meropenem in the treatment of complicated skin and soft tissue infections

@ast

Meropenem in the treatment of complicated skin and soft tissue infections

@en

prefLabel

Meropenem in the treatment of complicated skin and soft tissue infections

@ast

Meropenem in the treatment of complicated skin and soft tissue infections

@en

P1476

Meropenem in the treatment of complicated skin and soft tissue infections

@en

P2093

Douglas N Fish

http://www.w3.org/2001/XMLSchema#string

P2860

Wound microbiology and associated approaches to wound management

Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem

Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002.

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Optimal treatment of complicated skin and skin structure infections.

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.

Complicated infections of skin and skin structures: when the infection is more than skin deep.

Diagnosis and treatment of diabetic foot infections.

P304

401-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.2006.2.4.401

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5491049

http://www.w3.org/2001/XMLSchema#string

P698

18360652

http://www.w3.org/2001/XMLSchema#string

P932

1936361

http://www.w3.org/2001/XMLSchema#string

Meropenem in the treatment of complicated skin and soft tissue infections

about

P2860

P2860

Meropenem in the treatment of complicated skin and soft tissue infections

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932